Skip to content

Expiratory muscle training in chronic heart failure

The pulmonary effects of expiratory muscle training device Threshold PEP to decrease dyspnoea symptoms in patients with systolic heart failure.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12617001296325
Acronym
EMTHF
Enrollment
23
Registered
2017-09-08
Start date
2017-07-10
Completion date
2017-07-10
Last updated
2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The patients with chronic heart failure (CHF) suffer from low exercise tolerance, dyspnea and increased fatigue. The quality of life is very low because of the symptoms accompanying the CHF. The methodology of respiration therapy by means of any expiratory aids in patients with CHF has not yet been described in foreign countries. The expiratory muscle training with the treshold PEP device at home will lead to the improvement of the quality of life. The main intention of this study is to find a way how to effectively, cheaply and easily minimize the consecuences of heart failure.

Interventions

The patient was advised to undertake a 10 week expiratory muscles training program with Threshold Positive expiratory preassure (Treshold PEP), which he was taught by a physiotherapist in the hospital and with which he continued at home. The Treshold PEP is a small respiratory device to which the patient breathes against resistance and strenghtens his expiratory muscles. This device is advised to be used half an hour every day for the duration of 10 weeks. Every patient recieves a plan based on

The patient was advised to undertake a 10 week expiratory muscles training program with Threshold Positive expiratory preassure (Treshold PEP), which he was taught by a physiotherapist in the hospital and with which he continued at home. The Treshold PEP is a small respiratory device to which the patient breathes against resistance and strenghtens his expiratory muscles. This device is advised to be used half an hour every day for the duration of 10 weeks. Every patient recieves a plan based on their initial examination results. All patients, who refused expiratory muscle training were, with approval, included in the control group - it is consecutive group of patients. These patients went through identical initial and leaving examinations: anamnesis, clinical examination, spirometry, plethysmography, blood gas levels were determined and the patients also completed the modified Medical Research Council dyspnea questionnaires. A six-minute walk test (6-MWT) was performed with patients, also, the chest parameters in the mesosternale and xiphosternale level were measured.

Sponsors

University Hospital Brno
Lead SponsorHospital

Study design

Allocation
Non-randomised trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
No minimum to 75 Years
Healthy volunteers
No

Inclusion criteria

systolic heart failure all etiology New York Heart Association (NYHA) II-III ejection fraction of the left ventricle (EF LV) less than 45% patients without lung diseases

Exclusion criteria

The patients can not have uncompensated heart failure, chronic lung disease or change of medication during the intervention.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026